Mega-cap stocks are the flavor of the season, and these three big names are the next set of contenders racing towards the $1 trillion market cap club.
A panel of advisors to the Food and Drug Administration (FDA) recently recommended Eli Lilly's Alzheimer's candidate.
/Biogen%20Inc%20logo%20on%20HQ-by%20Tada%20Images%20via%20Shutterstock.jpg)
Biogen underperforms the Nasdaq Composite, and analysts remain cautiously optimistic about the stock’s prospects.
/Vertex%20Pharmaceuticals%2C%20Inc_%20HQ%20in%20Boston-by%20Tada%20Images%20via%20Shuttershock.jpg)
Vertex has outperformed the S&P 500 over the past year, and analysts are moderately bullish on the stock.
EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END
/AMGEN%20Inc_%20logo%20on%20meds-by%20Melnikov%20Dmitriy%20via%20Shutterstock.jpg)
Amgen has outperformed the S&P 500, and analysts remain optimistic about the stock’s prospects because of the positive Phase 2 clinical trial data of its obesity drug MariTide.
June S&P 500 E-Mini futures (ESM24) are trending down -0.05% this morning as warnings from a series of Federal Reserve officials prompted investors to reassess their expectations regarding interest rate...
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. US stock...
The S&P 500 Index ($SPX ) (SPY ) is down -0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.09%. US stock indexes are moderately...